"Budgets" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Detailed financial plans for carrying out specific activities for a certain period of time. They include proposed income and expenditures.
| Descriptor ID |
D002017
|
| MeSH Number(s) |
N03.219.463.060
|
| Concept/Terms |
Budgetary Control- Budgetary Control
- Budgetary Controls
- Control, Budgetary
- Controls, Budgetary
|
Below are MeSH descriptors whose meaning is more general than "Budgets".
Below are MeSH descriptors whose meaning is more specific than "Budgets".
This graph shows the total number of publications written about "Budgets" by people in this website by year, and whether "Budgets" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2007 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2015 | 1 | 1 | 2 |
| 2018 | 1 | 2 | 3 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 1 | 2 |
| 2023 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Budgets" by people in Profiles.
-
Morgans AK, Grossman JP, Paracha N, Ladino D, Tyas E, Rodriguez-Santamaria F, Shore N. Within-trial hospitalization resource utilization and budget impact analysis for darolutamide in metastatic hormone-sensitive prostate cancer using ARASENS. J Manag Care Spec Pharm. 2024 Sep; 30(9):991-1000.
-
Lazar EL, Schwartz TA, Zuckerbraun BS. Practical Guide to Budgeting and Funding a Clinical Trial in Surgery. JAMA Surg. 2023 02 01; 158(2):206-207.
-
Diptyanusa A, Zablon KN. Addressing budget reduction and reallocation on health-related resources during COVID-19 pandemic in malaria-endemic countries. Malar J. 2020 Nov 16; 19(1):411.
-
Wallace K, Adamski K, Pai A, Rose D, Chawla A. The Budget Impact of Including Rucaparib on a US Payer Formulary for the Treatment of Patients with Metastatic Ovarian Cancer. Pharmacoeconomics. 2021 02; 39(2):231-241.
-
Pizzi LT, Prioli KM, Herman JH. Authors' Reply to Mintz: "Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model". Appl Health Econ Health Policy. 2019 04; 17(2):259-261.
-
Prioli KM, Karp JK, Lyons NM, Chrebtow V, Herman JH, Pizzi LT. Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model. Appl Health Econ Health Policy. 2018 12; 16(6):889-899.
-
May BJ, Khoury JK, Winokur RS. Tools for Simulation; Low Budget and No Budget. Tech Vasc Interv Radiol. 2019 Mar; 22(1):3-6.
-
Mamas MA, Tosh J, Hulme W, Hoskins N, Bungey G, Ludman P, de Belder M, Kwok CS, Verin N, Kinnaird T, Bennett E, Curzen N, Nolan J, Kontopantelis E. Health Economic Analysis of Access Site Practice in England During Changes in Practice: Insights From the British Cardiovascular Interventional Society. Circ Cardiovasc Qual Outcomes. 2018 05; 11(5):e004482.
-
Hohnloser SH, Cappato R, Ezekowitz MD, Evers T, Sahin K, Kirchhof P, Meng IL, van Eickels M, Camm AJ. Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial. Europace. 2016 Feb; 18(2):184-90.
-
Mazerolle SM, Raso SR, Pagnotta KD, Stearns RL, Casa DJ. Athletic Directors' Barriers to Hiring Athletic Trainers in High Schools. J Athl Train. 2015 10; 50(10):1059-68.